IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
Kurbegovic S, Juhl K, Sørensen KK, Leth J, Willemoe GL, Christensen A, Adams Y, Jensen AR, von Buchwald C, Skjøth-Rasmussen J, Ploug M, Jensen KJ, Kjaer A.
Kurbegovic S, et al. Among authors: jensen ar, jensen kj.
Theranostics. 2021 May 21;11(15):7159-7174. doi: 10.7150/thno.49787. eCollection 2021.
Theranostics. 2021.
PMID: 34158842
Free PMC article.